Insider Transactions Reported by 15 Insiders of Lineage Cell Therapeutics, Inc.

Symbol
LCTX on NYSE
Location
Carlsbad, CA

Insiders trading volume in the past year

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BROADWOOD PARTNERS, L.P. Director, 10%+ Owner $75,332,708 +$6,000,000 +8.7% 27 Jan 2025
Brian M. Culley President and CEO, Director $373,186 19 Dec 2025
Michael H. Mulroy Director $168,982 01 Jul 2025
DON M. BAILEY Director $165,153 01 Jul 2024
Neal C. Bradsher Director, 10%+ Owner $52,500 01 Jul 2025
George A. Samuel III General Counsel and Secretary $46,183 19 Dec 2025
Jill A. Howe Chief Financial Officer $15,045 10 Mar 2025
Dipti Amin Director 01 Jul 2025
DEBORAH J. ANDREWS Director 01 Jul 2025
Kevin Leon Cook Chief Financial Officer 10 Mar 2022
Anula Jayasuriya Director 01 Jul 2025
Gary S. Hogge SVP,Clinical & Medical Affairs 09 Mar 2023
Alexandra Hernandez Sr Director Finance/Controller 07 Jul 2022
Angus C. Russell Director 01 Jul 2025
ALFRED D. KINGSLEY Chairman, Director 01 Jul 2023

Recent Insider Transactions by Companies or Individuals for Lineage Cell Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.